ESSA Pharma Inc. (EPIX)

ESSA Pharma Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Year Ending	TTM	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cash & Equivalents	91.94	33.96	57.34	138.08	56.6	53.6
Short-Term Investments	44.21	114.37	110.16	57.1	22.01	0
Cash & Cash Equivalents	136.15	148.33	167.5	195.19	78.61	53.6
Cash Growth	-13.45%	-11.44%	-14.19%	148.30%	46.67%	256.59%
Receivables	0.22	0.14	0.01	0.49	0.31	0.36
Other Current Assets	0.94	0.33	1.56	1.92	1.38	0.34
Total Current Assets	137.3	148.8	169.06	197.6	80.3	54.3
Property, Plant & Equipment	0.34	0.07	0.19	0.31	0.06	0
Other Long-Term Assets	0.26	0.26	0.26	0.26	0.22	0.27
Total Long-Term Assets	0.6	0.33	0.45	0.57	0.28	0.27
Total Assets	137.9	149.12	169.51	198.17	80.57	54.57
Accounts Payable	4.07	3.41	2.18	3.81	1.14	1.57
Current Debt	0.1	0.08	0.13	0.12	0.06	3.71
Other Current Liabilities	0	0	0	0	0	0.3
Total Current Liabilities	4.17	3.5	2.31	3.93	1.2	5.57
Long-Term Debt	0.25	0	0.08	0.21	0	0
Other Long-Term Liabilities	0	0	0	0.02	0.13	0.02
Total Long-Term Liabilities	0.25	0	0.08	0.23	0.13	0.02
Total Liabilities	4.43	3.5	2.39	4.16	1.33	5.59
Total Debt	0.35	0.08	0.21	0.33	0.06	3.71
Debt Growth	143.45%	-61.79%	-36.47%	460.07%	-98.41%	-41.29%
Retained Earnings	-194.42	-179.46	-152.88	-117.78	-80.97	-57.52
Comprehensive Income	-2.1	-2.12	-2.14	-2.08	-2.08	-2.08
Shareholders' Equity	133.47	145.63	167.12	194.01	79.24	48.98
Net Cash / Debt	135.79	148.25	167.29	194.86	78.55	49.89
Net Cash / Debt Growth	-13.60%	-11.38%	-14.15%	148.06%	57.45%	472.53%
Net Cash Per Share	3.07	3.36	3.80	5.06	3.50	5.92
Working Capital	133.12	145.3	166.75	193.67	79.09	48.72
Book Value Per Share	3.02	3.30	3.79	5.04	3.53	5.81

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).